DK201600379A1 - Detumescence Odynolysis Ointment - Google Patents

Detumescence Odynolysis Ointment Download PDF

Info

Publication number
DK201600379A1
DK201600379A1 DKPA201600379A DKPA201600379A DK201600379A1 DK 201600379 A1 DK201600379 A1 DK 201600379A1 DK PA201600379 A DKPA201600379 A DK PA201600379A DK PA201600379 A DKPA201600379 A DK PA201600379A DK 201600379 A1 DK201600379 A1 DK 201600379A1
Authority
DK
Denmark
Prior art keywords
odynolysis
detumescence
ointment
injury
bone
Prior art date
Application number
DKPA201600379A
Inventor
Xiaoying Liu
Original Assignee
Tingen Tech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tingen Tech Co Ltd filed Critical Tingen Tech Co Ltd
Publication of DK201600379A1 publication Critical patent/DK201600379A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/28Mercury; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • A61K35/644Beeswax; Propolis; Royal jelly; Honey
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/31Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/71Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A61K36/716Clematis (leather flower)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Insects & Arthropods (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Animal Husbandry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Description

DETUMESCENCE ODYNOLYSIS OINTMENT TECHNICAL FIELD
The present invention discloses a detumescence odynolysis ointment. BACKGROUND
Chinese medicine treatment of traumatic injury has several thousands of years of history. The traumatic injury usually refers to soft tissue injury caused by external force action or overexerting in the case of improper posture, and is expressed as swelling and pain. In the field of traditional Chinese medicine, all of muscle and bone injury, ecchymoma, vital energy and blood at odds, main and collateral channels blocking, and visceral organ damage are uniformly called traumatic injury. In the prior art, a fuming and washing medical composition prepared from Angelica sinensis, Panax notoginseng, flos carthami, Radix Paeoniae Alba, Radix Achyranthis Bidentatae, myrrh, frankincense and trogopterus dung, is selected for treatment, which has the effect in promoting circulation and removing stasis, relieving pain and eliminating swelling; but it is only palliative. When the traumatic injury just occurs, patients often suffer from unbearable pain, and hope to adopt some effective treatment methods to relieve pain, so they tend to use fuming and washing medicine to perform fuming and washing immediately, this behavior easily results in intensive dilation of blood vessel in the wounded part, to thereby aggravate errhysis and edema, which not only will lead to soft tissue adhesion and partial function weakening, but also easily aggravate pain feeling. Existing correct behavior of cold compress can cause vasoconstriction in the wounded part, and reduce bleeding, swelling and pain, however, its alleviation capacity is limited, the patients still have to endure severe pain, resulting in inconvenience for the normal physical activities.
Therefore, it is necessary to develop a detumescence odynolysis ointment which can be used immediately when traumatic injury just occurs, to relieve pain in time, promote vasoconstriction and further inhibit the occurrence of bleeding and swelling.
SUMMARY OF THE INVENTION
The present invention aims at providing a detumescence odynolysis ointment having good comprehensive pharmaceutical property and good treatment effect, and prepared by taking dog leg bone as main raw material, and combining the effects of traditional medicinal materials and research achievements of modem pharmacology.
For this purpose, the present invention discloses a detumescence odynolysis ointment, comprising by weight parts: dog leg bone 20-35, ground beetle 10-15, goat blood 6-10, menthol 4-8, Semen Brassicae 4-8, frankincense 1-3, cinnabar 1-3, Sanguinem Draconis 1-3, and honey 3-5.
According to one embodiment of the present invention, the detumescence odynolysis ointment comprises by weight parts: dog leg-bone 21, ground beetle 11, goat blood 6, menthol 5, Semen Brassicae 5, frankincense 1, cinnabar 1, Sanguinem Draconis 1, and honey 3.
According to one embodiment of the present invention, the detumescence odynolysis ointment comprises by weight parts: dog leg-bone 26, ground beetle 12, goat blood 7, menthol 6, Semen Brassicae 5, frankincense 2, cinnabar 1, Sanguinem Draconis 2, and honey 4.
According to one embodiment of the present invention, the detumescence odynolysis ointment comprises by weight parts: dog leg- bone 33, ground beetle 14, goat blood 8, menthol 7, Semen Brassicae 6, frankincense 2, cinnabar 2, Sanguinem Draconis 2, and honey 5.
According to one embodiment of the present invention, the detumescence odynolysis ointment further comprises by weight parts: akebiaquinata 3-8.
The above detumescence odynolysis ointment is prepared and administrated as follows : weighing all of the raw materials according to their weight parts, mixing and grinding the same to obtain a paste; weighing appropriate amounts of sesame oil and yellow lead, and decocting the same to obtain a black factice; weighing 5kg of the black factice, gently heating it to melt, adding 1.5kg of the ground Chinese medicine paste, and uniformly stirring; spreading 20-30g of the Chinese medicine ointment on a soft cloth, and pasting it at the swelling and pain position, replaced once for every day, and a treatment course of 5 times of administration.
The raw materials of detumescence odynolysis ointment have the pharmacological performances as follows:
Dog leg-bone: The bone of Canidae animal-dog, has solid sclerotin, not very heavy weight, color of white or pale yellow, not even cross section, and not obvious inner net-like medulla. After a dog is killed, the muscles on its bone is removed, and the bone is air dried in a place with good ventilation; the bone cannot be solarized, to avoid oil leaking and color changing. It has the effect in tonifying spleen and main and collateral channels, invigorating the circulation of blood, and promote tissue regeneration.
Ground beetle (name from traditional Chinese medicine): The dried body of female insect of the family Corydiidae Eupolyphaga Sinensis
Walker or Steleophaga Plancyi (Boleny). After the female insect is caught, it is scalded in boiling water to die, and then followed by drying in the sun or stove drying. It is distributed in Hebei, Shanxi, Gansu, Qinghai, Shandong, Henan, Jiangsu, Zhejiang, Hunan, etc. It has the effect in breaking blood and removing stasis, and promoting reunion of fractured bones; and is used for the treatment of traumatic injury, injury of tendon and muscle, fracture, blood stasis and amenorrhea, postpartum stasis and stomachache, and lump in the abdomen.
Goat blood: its preparation method is recorded in “YUE XI OU JI”, “BEN JING FENG YUAN”, and “GANG MU SHI ΥΓ of Chinese document “BEN CAO HUI YAN”.
Menthol: is a chemical medicine, extracted from the leaf and stem of mint, white crystal, and main ingredient of mint essential oil, and has molecular formula of C10H20O. In the world, India is a major producer of natural mint. Both menthol and racemic menthol can be used as an odorant of toothpaste, perfume, drink and candy. In medicine, it can be applied to the skin or mucosa as stimulating drug, to exert the effects of refreshing and relieving itching; it can also be taken orally as carminative medicine for headache, rhinitis, pharyngitis and laryngitis. The ester thereof is used for perfume and medicine.
Semen Brassicae: Latin name of Semen sinapis. It is dried matured seed of annual or biennial plant-Sinapis alba L.in Brassicaceae. It has spherical shape, off-white or pale yellow surface, thin and crisp seed coat, oiliness, odorless smell, bitter taste, and can be used as medicine. It is mainly produced in Anhui, Henan, Sichuan, Shandong, etc., and cultivated in various places of China.
Frankincense: traditional Chinese medicine name, is a resin exudated from the bark of Boswellia carterii Birdw. in Burseraceae and congener plant- Boswellia bhaurdajiana Birdw. It is classified into Somalian frankincense and Ethiopian frankincense, each being classified into frankincense bead and original frankincense.
Cinnabar: has many aliases such as vermillion, is a natural ore of mercuric sulfide (HgS), bright red, has adamantine luster or metallic luster, and belongs to trigonal system. The main ingredient of the cinnabar is mercuric sulfide, but usually mixed up with realgar, apatite, asphaltene, etc. The sedative and hypnotic effect of the cinnabar have not been confirmed. It does have detoxifying effect and preservative effect, can inhibit or kill skin bacteria and parasite. It is a compound of mercury, which has special affinity with mercapto in proteins and can inhibit various enzymes and activities at high concentration. After entering into the human body, mercury is mainly distributed in the liver and kidney, to thereby cause liver and kidney damage; it also can pass through the blood-brain barrier, and directly damage the central nervous system.
Sanguinem Draconis: (name from traditional Chinese medicine), is prepared by processing resin exudated from the fruit of Arecaceae plant-Daemonorop draco. It is distributed in Indonesia, Java, Sumatra, Borneo, etc.; has the effect in invigorating the circulation of blood and relieving pain, dispersing blood stasis and stop bleeding, promoting tissue regeneration and astringing ulcer; and can be used for the treatment of traumatic injury, heart and abdomen blood pain, traumatic bleeding, no astringing of swelling and ulcer on the body surface.
Honey: brewed in honeycomb in which nectar collected from flowers of bloomer by bee is located.
Akebiaquinata (name from traditional Chinese medicine): is a dried rattan of Lardizabalaceae plant-Akebia quinata (Thunb.) Decne., Akebia tri-foliata (Thunb.) Koidz., or Akebia tri-foliata (Thunb.) Koidz.; or
Australis (Diels) Rehd. It is harvested in autumn, and prepared by cutting to obtain a stem part, removing withes and drying in the shade.
The detumescence odynolysis ointment provided in the present invention has special effects for sprain, contusion, fracture, nonunion, difficult joint bending after plaster immobilization or operation, waist sprain, sprained ankle, ischialgia, ligamentous injury, pulled muscle, tendon injury, meniscus injury and soft tissue injury.
Other features and advantages of the present invention will be described in detail in a subsequent section of the specific embodiments.
DETAILED DESCRIPTION OF THE EMBODIMENTS
The present invention provides many applicable inventive concepts, which can be widely embodied in the specific context. Specific examples described in the following embodiments of the present invention are only as exemplary illustrations for the specific implementation of the present invention, and are not constructed to limit the scope of the present invention.
Without loss of generality, the present invention discloses a detumescence odynolysis ointment, comprising by weight parts: dog leg bone 20-35, ground beetle 10-15, goat blood 6-10, menthol 4-8, Semen Brassicae 4-8, frankincense 1-3, cinnabar 1-3, Sanguinem Draconis 1-3, and honey 3-5.
Wherein, all the above raw materials can be commercially available finished products, and also can be obtained with common preparation method, for example, can be prepared by drying and pulverizing crude materials into commonly-used powder in the art. The drying method can be baking or naturally drying, and preferably naturally drying. The pulverizing method can be a commonly-used method in the field of traditional Chinese medicine, and the average particle size of the pulverized materials is preferably 20-30 mesh, and more preferably 20 mesh.
The detumescence odynolysis ointment provided in the present invention has special effects for sprain, contusion, fracture, nonunion, difficult joint bending after plaster immobilization or operation, waist sprain, sprained ankle, ischialgia, ligamentous injury, pulled muscle, tendon injury, meniscus injury and soft tissue injury.
For further implementing above technical solution, the preparation method and administration method of above detumescence odynolysis ointment are as follows: weighing all of the raw materials according to their weight parts, mixing and grinding the same to obtain a paste; weighing appropriate amounts of sesame oil and yellow lead, and decocting the same to obtain a black factice; weighing 5kg of the black factice, gently heating it to melt, adding 1.5kg of the ground Chinese medicine paste, and uniformly stirring; spreading 20-30g of the Chinese medicine ointment on a soft cloth, and pasting it at the swelling and pain position, replaced once for every day, and a treatment course of 5 times of administration.
It should be noted that since the production process of above black factice belongs to the prior art, the relevant details thereof are not described herein. The present invention only utilizes the glutinousness of the black factice to adhere the ointment at swelling and pain position.
One day of administration of above detumescence odynolysis ointment can produce the desired result, two days of administration thereof can remarkably alleviate the symptom, two courses of treatment can allow a patient to recover capacity for action, and four courses of treatment can allow a patient to recover to health.
Below, the present invention will be described in more detail through the examples.
Examples 1-5
Examples 1-5 are used to illustrate the detumescence odynolysis ointment provided in the present invention.
According to the weight parts listed in Table 1, detumescence odynolysis ointments 1-5 are obtained.
Table 1
Experimental examples 1-5
Experimental examples 1-5 are used to illustrate the treatment effect of the Detumescence odynolysis ointment provided in the present invention. (1) The alleviation effect for sprain and contusion 150 male and female patients (in the age range of 30-70) with the sprain and contusion at different degrees are selected, and randomly divided into five groups, with 30 patients in each group. The Detumescence odynolysis ointments 1-5 are used in the five groups, respectively. For administration, the Detumescence odynolysis ointment is pasted at the injury positions (replaced once a day, a treatment course of 5 times), and after 4 courses of treatment, the effects are observed, wherein compared with a condition before administration, the patient whose symptom completely disappears is marked as o, the patient whose symptom is remarkably alleviated is marked as Δ, and the patient whose symptom has no remarkable alleviation is marked as x, and the treatment effects are shown in Table 2.
Table 2
(2) The alleviation effect for fracture, nonunion, difficult joint bending after plaster immobilization or operation 150 male and female patients (in the age range of 35-65) with above symptoms at different degrees are selected, and randomly divided into five groups, with 30 patients in each group. The Detumescence odynolysis ointments 1-5 are used in the five groups, respectively. For administration, the Detumescence odynolysis ointment is pasted at the injury positions (replaced once a day, a treatment course of 5 times), and after 4 courses of treatment, the effects are observed, wherein compared with a condition before administration, the patient whose symptom completely disappears is marked as o, the patient whose symptom is remarkably alleviated is marked as Δ, and the patient whose symptom has no remarkable alleviation is marked as x, and the treatment effects are shown in Table 3.
Table 3
(3) The alleviation effect for waist sprain, sprained ankle, ischialgia, ligamentous injury, pulled muscle, tendon injury, meniscus injury and soft tissue injury 150 male and female patients (in the age range of 55-70) with above symptoms at different degrees are selected, and randomly divided into five groups, with 30 patients in each group. The Detumescence odynolysis ointments 1-5 are used in the five groups, respectively. For administration, the Detumescence odynolysis ointment is pasted at the injury positions (replaced once a day, a treatment course of 5 times), and after 4 courses of treatment, the effects are observed, wherein compared with a condition before administration, the patient whose symptom completely disappears is marked as o, the patient whose symptom is remarkably alleviated is marked as Δ, and the patient whose symptom has no remarkable alleviation is marked as x, and the treatment effects are shown in Table 4.
Table 4
It can be seen from above test results of the test examples that: the detumescence odynolysis ointment provided in the present invention has special effects for sprain, contusion, fracture, nonunion, difficult joint bending after plaster immobilization or operation, waist sprain, sprained ankle, ischialgia, ligamentous injury, pulled muscle, tendon injury, meniscus injury and soft tissue injury.

Claims (5)

1. A detumescence odynolysis ointment, comprising by weight parts: dog leg-bone 20-35, ground beetle 10-15, goat blood 6-10, menthol 4-8, Semen Brassicae 4-8, frankincense 1-3, cinnabar 1-3, Sanguinem Draconis 1-3, and honey 3- 5.
2. The detumescence odynolysis ointment according to claim 1, comprising by weight parts: dog leg-bone 21, ground beetle 11, goat blood 6, menthol 5, Semen Brassicae 5, frankincense 1, cinnabar 1, Sanguinem Draconis 1, and honey 3.
3. The detumescence odynolysis ointment according to claim 1, comprising by weight parts: dog leg-bone 26, ground beetle 12, goat blood 7, menthol 6, Semen Brassicae 5, frankincense 2, cinnabar 1, Sanguinem Draconis 2, and honey 4.
4. The detumescence odynolysis ointment according to claim 1, comprising by weight parts: dog leg-bone 33, ground beetle 14, goat blood 8, menthol 7, Semen Brassicae 6, frankincense 2, cinnabar 2, Sanguinem Draconis 2, and honey 5.
5. The detumescence odynolysis ointment according to any one of claims 1-4, further comprising by weight parts: akebiaquinata 3-8.
DKPA201600379A 2015-11-02 2016-06-24 Detumescence Odynolysis Ointment DK201600379A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510729337 2015-11-02

Publications (1)

Publication Number Publication Date
DK201600379A1 true DK201600379A1 (en) 2017-05-15

Family

ID=58545857

Family Applications (1)

Application Number Title Priority Date Filing Date
DKPA201600379A DK201600379A1 (en) 2015-11-02 2016-06-24 Detumescence Odynolysis Ointment

Country Status (3)

Country Link
KR (1) KR20170051126A (en)
DE (1) DE102016002122A1 (en)
DK (1) DK201600379A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107308188A (en) * 2016-05-24 2017-11-03 张来志 Huangshi ointment
CN107929469A (en) * 2017-12-29 2018-04-20 张华丰 A kind of Chinese medicine for treating fracture and preparation method thereof
KR102215158B1 (en) * 2019-09-10 2021-02-10 강성익 Composition of pain relief patch and method of making the patch
CN110623983A (en) * 2019-11-08 2019-12-31 杨建敏 Medicine for dredging channels, removing stasis and relieving pain

Also Published As

Publication number Publication date
DE102016002122A1 (en) 2017-05-04
KR20170051126A (en) 2017-05-11

Similar Documents

Publication Publication Date Title
CN104288538A (en) Plaster for treating neck, shoulder, waist and leg diseases and preparation method of plaster
DK201600379A1 (en) Detumescence Odynolysis Ointment
CN101524450B (en) Oral traditional Chinese medicine for setting bones and relieving rigidity of muscles and preparation method thereof
CN108403911A (en) A kind of medicinal liquor for treating traumatic injury
CN104095948A (en) Externally-applied bath agent for treating heel pain
CN102895365B (en) External ointment for treating bone injury and orthopedics inflammation
CN103656025B (en) A kind of medical liquor for treating injury
CN111228445A (en) Medicinal liquor for detumescence and stasis-removing for traumatic injury and preparation method thereof
CN103566056A (en) Plaster for treating traumatic injury
CN102258670A (en) Medicine for treating calcaneodynia
CN108498617A (en) Rheumatalgia Chinese medicine composition and its preparation method and application, lavipeditum packet and preparation method thereof and pharmaceutical preparation
CN104225534A (en) Ointment for treating waist, shoulder and foot rheumatism and preparation method of ointment
CN103386064A (en) Traditional Chinese medicine patch
CN104474153A (en) Medicine used for diminishing inflammation, relieving pain,eliminating blood stasis and promoting tissue regeneration
CN104491745B (en) A kind of Chinese medicine for treating Bones and joints and soft tissue injury and its application
CN102274362B (en) Plaster for treating mastopathy and preparation method thereof
CN105853760A (en) Orthopedic plaster and preparation method thereof
CN102579675A (en) Astragalus notoginseng root body resistance strengthening pills
CN105727177A (en) Medicine for treating traumatic injuries
CN104257931A (en) Orthopedic traumatic injury external application patch and preparation method thereof
CN114404469A (en) Swelling-diminishing and pain-relieving ointment for rheumatic bone injuries
CN104784284A (en) Blood circulation promoting ointment and preparation method thereof
CN103285109A (en) Chinese herbal medicine for treating bone fracture and preparation method thereof
CN104547947A (en) Traditional Chinese medicine composition for treating scapulohumeral periarthritis
CN118217346A (en) Swelling-diminishing, collateral-dredging and pain-relieving ointment and preparation method and application thereof

Legal Events

Date Code Title Description
PHB Application deemed withdrawn due to non-payment or other reasons

Effective date: 20180702